Special NoticeActiveCBER-2026-133723
Notice of Intent to Sole Source: Vaccine Adverse Event Reporting System (VAERS) & Safety Monitoring Support
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCSKey dates?
- Posted?
- Sep 10, 2026
- Response deadline?
- Sep 18, 2026, 7:30 PM UTC
- Archive date?
- Sep 18, 2026
- Archive type?
- autocustom
Classification?
- Notice type?
- Special Notice
- Base type?
- Special Notice
- Set-aside?
- 8(a) Set-Aside (FAR 19.8)
- Set-aside code?
- 8A
- PSC?
- AJ11
NAICS?
Issuing office?
- Department?
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Sub-tier?
- FOOD AND DRUG ADMINISTRATION
- Office?
- FDA OFFICE OF ACQ GRANT SVCS
- Office code?
- —
- Organization type?
- OFFICE
- Office address?
- Rockville, MD, 20852, USA
Place of performance?
- Street?
- —
- Street 2?
- —
- City?
- Carmel
- State?
- CA
- Zip?
- 93923
- Country?
- USA
Contacts?
- Rodney D. Aytchprimary
Description?
The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER)’s Office of Biostatistics and Pharmacovigilance (OPBV)’s Division of Pharmacovigilance (DPV) is responsible for monitoring the safety of vaccines and biologics once they are approved for use under a Biologic Licensing Application (BLA) or authorized for use under an Emergency Use Authorization (EUA). The Contractor shall furnish the necessary services and qualified personnel needed to perform the Statement of Work.
Similar open contracts
Metadata?
- Notice ID?
- 074c7f0416bf4356ba526140dc9488e9
- Full path?
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF.FOOD AND DRUG ADMINISTRATION.FDA OFFICE OF ACQ GRANT SVCS
- Office code?
- —
- Ingested?
- Sep 13, 2026
- Updated?
- Sep 13, 2026